Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Product sales, net $ 3,865 $ 4,089 $ 11,821 $ 12,203
Cost of goods sold 2,087 2,246 6,330 6,860
Gross profit 1,778 1,843 5,491 5,343
Operating expenses:        
Research and development 29 40 93 111
Selling, general and administrative 2,090 2,240 6,942 7,154
Benefit from reversal of accrued payroll taxes (Note 12) 0 0 0 (6,171)
 Total operating expenses 2,119 2,280 7,035 1,094
Operating income (loss) (341) (437) (1,544) 4,249
Other expense, net 115 10 118 275
Income (loss) before income taxes (456) (447) (1,662) 3,974
Income tax expense 0 0 6 3
Net income (loss) $ (456) $ (447) $ (1,668) $ 3,971
Weighted average common shares outstanding, basic (in shares) 182,261 154,604 172,671 153,112
Weighted average common shares outstanding, diluted (in shares) 182,261 154,604 172,671 153,112
Net income (loss) per common share, basic (in USD per share) $ (0) $ (0) $ (0.01) $ 0.03
Net income (loss) per common share, basic diluted (in USD per share) $ (0) $ (0) $ (0.01) $ 0.03
Revenue, product and service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember